KR102459500B1 - 퀘르세틴 배당체를 함유하는 근위축 억제제 - Google Patents

퀘르세틴 배당체를 함유하는 근위축 억제제 Download PDF

Info

Publication number
KR102459500B1
KR102459500B1 KR1020167032953A KR20167032953A KR102459500B1 KR 102459500 B1 KR102459500 B1 KR 102459500B1 KR 1020167032953 A KR1020167032953 A KR 1020167032953A KR 20167032953 A KR20167032953 A KR 20167032953A KR 102459500 B1 KR102459500 B1 KR 102459500B1
Authority
KR
South Korea
Prior art keywords
muscle
quercetin
atrophy
muscle atrophy
dexamethasone
Prior art date
Application number
KR1020167032953A
Other languages
English (en)
Korean (ko)
Other versions
KR20160146980A (ko
Inventor
유타 오츠카
가호리 에가와
노리유키 간자키
Original Assignee
산토리 홀딩스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산토리 홀딩스 가부시키가이샤 filed Critical 산토리 홀딩스 가부시키가이샤
Publication of KR20160146980A publication Critical patent/KR20160146980A/ko
Application granted granted Critical
Publication of KR102459500B1 publication Critical patent/KR102459500B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • Y10S514/906—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020167032953A 2014-04-28 2015-04-24 퀘르세틴 배당체를 함유하는 근위축 억제제 KR102459500B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014092855 2014-04-28
JPJP-P-2014-092855 2014-04-28
PCT/JP2015/062533 WO2015166887A1 (fr) 2014-04-28 2015-04-24 Inhibiteur de l'atrophie musculaire contenant un glycoside de quercétine

Publications (2)

Publication Number Publication Date
KR20160146980A KR20160146980A (ko) 2016-12-21
KR102459500B1 true KR102459500B1 (ko) 2022-10-26

Family

ID=54358616

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167032953A KR102459500B1 (ko) 2014-04-28 2015-04-24 퀘르세틴 배당체를 함유하는 근위축 억제제

Country Status (12)

Country Link
US (1) US20170042924A1 (fr)
EP (1) EP3138570A4 (fr)
JP (2) JP6849433B2 (fr)
KR (1) KR102459500B1 (fr)
CN (1) CN106255504A (fr)
AU (1) AU2015254309B2 (fr)
CA (1) CA2946825C (fr)
MY (1) MY194893A (fr)
RU (1) RU2016146115A (fr)
SG (2) SG11201608760WA (fr)
TW (1) TWI757228B (fr)
WO (1) WO2015166887A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
CA2982645C (fr) * 2015-04-27 2024-02-13 Suntory Holdings Limited Composition permettant de supprimer un changement adipeux musculaire
WO2017085190A1 (fr) 2015-11-17 2017-05-26 Nestec S.A. Compositions et procédés employant un polyphénol pour la santé musculosquelettique
WO2017186954A1 (fr) * 2016-04-28 2017-11-02 Legacy Healthcare Ltd Procédé d'amélioration de la vitesse et de la capacité d'endurance
JP2018087175A (ja) * 2016-11-30 2018-06-07 花王株式会社 筋萎縮抑制剤
CA3055164A1 (fr) * 2017-03-10 2018-09-13 Suntory Holdings Limited Composition pour l'inhibition de myofibrose
WO2021033995A1 (fr) * 2019-08-16 2021-02-25 고려제약주식회사 Composition comprenant un extrait d'amomum tsaoko pour prévenir, atténuer ou traiter une maladie liée à la sarcopénie
TW202216145A (zh) * 2020-06-30 2022-05-01 日商東麗股份有限公司 伴隨代謝異常之疾病或症候群中的肌力低下症狀之改善劑或預防劑
AU2021398645A1 (en) * 2020-12-18 2023-06-29 Suntory Holdings Limited Composition for improving muscle flexibility
CN117396209A (zh) * 2021-05-21 2024-01-12 阿尼姆斯 医药科技有限公司 用于预防或治疗肌肉疾病的包含桦褐孔菌醇的组合物
CA3219821A1 (fr) * 2021-05-21 2022-11-24 Sang-Jin Lee Composition comprenant un inotodiol pour la prevention ou le traitement d'une maladie musculaire
JPWO2022255276A1 (fr) * 2021-06-03 2022-12-08
CN117298077B (zh) * 2023-11-29 2024-02-13 山东海之宝海洋科技有限公司 Trifuhalol A在改善肌肉萎缩中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012012327A (ja) * 2010-06-30 2012-01-19 Morinaga & Co Ltd 筋肥大促進のための食品、補助食品、及びサプリメント

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1917894A (zh) * 2004-02-10 2007-02-21 朝日啤酒株式会社 肌张力增强剂
JP2008156294A (ja) * 2006-12-25 2008-07-10 Lion Corp 筋芽細胞活性化剤
JP2009007313A (ja) * 2007-06-29 2009-01-15 Lion Corp 筋萎縮抑制剤
JP5326246B2 (ja) 2007-09-10 2013-10-30 国立大学法人三重大学 筋肉増加剤
MX2012004118A (es) * 2009-10-09 2012-05-08 Nestec Sa Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.
JP2013126951A (ja) * 2010-03-01 2013-06-27 Kyushu Univ 筋萎縮阻害剤
JP2012183063A (ja) * 2011-02-14 2012-09-27 Suntory Holdings Ltd ケルセチン配糖体配合容器詰め飲料
EP2580967A1 (fr) * 2011-10-11 2013-04-17 Nestec S.A. Accélération de récupération musculaire après une atrophie du muscle induite par l'immobilisation
JP2013091608A (ja) 2011-10-25 2013-05-16 Kao Corp ミオスタチン／Ｓｍａｄシグナル阻害剤
JP5948871B2 (ja) * 2011-12-28 2016-07-06 株式会社東洋新薬 ポリフェノール含有組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012012327A (ja) * 2010-06-30 2012-01-19 Morinaga & Co Ltd 筋肥大促進のための食品、補助食品、及びサプリメント

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Brazilian Journal of Pharmaceutical Sciences vol. 48, n. 4 (2012)*
J. Nat. Prod. 2010, 73, 1708-1710*
Journal of Nutritional Biochemistry 21 (2010) 1~13*
PLOS ONE, Volume 7, Issue 9 (2012)*

Also Published As

Publication number Publication date
NZ725458A (en) 2022-03-25
AU2015254309B2 (en) 2020-02-27
JPWO2015166887A1 (ja) 2017-04-20
JP2019210299A (ja) 2019-12-12
SG11201608760WA (en) 2016-11-29
CN106255504A (zh) 2016-12-21
AU2015254309A1 (en) 2016-11-10
JP6849433B2 (ja) 2021-03-24
SG10201809153WA (en) 2018-11-29
MY194893A (en) 2022-12-22
KR20160146980A (ko) 2016-12-21
TWI757228B (zh) 2022-03-11
JP6942165B2 (ja) 2021-09-29
CA2946825A1 (fr) 2015-11-05
EP3138570A1 (fr) 2017-03-08
EP3138570A4 (fr) 2017-12-20
WO2015166887A1 (fr) 2015-11-05
TW201625271A (zh) 2016-07-16
US20170042924A1 (en) 2017-02-16
CA2946825C (fr) 2022-08-23
RU2016146115A (ru) 2018-05-28

Similar Documents

Publication Publication Date Title
KR102459500B1 (ko) 퀘르세틴 배당체를 함유하는 근위축 억제제
CA2982645C (fr) Composition permettant de supprimer un changement adipeux musculaire
WO2011108487A1 (fr) Inhibiteur d'atrophie musculaire
JP7379152B2 (ja) 筋線維化抑制用組成物
CA3226805A1 (fr) Compositions de substitution de cafeine a base de paraxanthine et methode associee d'utilisation chez des sujets a metabolisme cafeique lent
KR102239075B1 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 근감소증의 예방 또는 치료용 약학 조성물
JP2017137296A (ja) アストロサイトのグルコース代謝活性化剤
KR101809379B1 (ko) 디오스민 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물
JP2013091608A (ja) ミオスタチン／Ｓｍａｄシグナル阻害剤
KR20220117115A (ko) 진토닌을 포함하는 근위축 또는 악액질의 예방 또는 치료용 약학적 조성물
JP5985292B2 (ja) Ｔｒｐｖ４活性抑制剤
German et al. New Trends to Treat Muscular Atrophy: Systematic Review
JP2014015429A (ja) サテライト細胞分化促進剤
WO2006006750A1 (fr) Procede permettant de preparer un extrait purifie de ginseng sauvage presentant une activite anticancereuse, et composition contenant cet extrait
KR101613252B1 (ko) 아르기나아제 억제제를 함유하는 비만 및 지방간 예방 또는 치료용 조성물
EP3159003A2 (fr) Composition pour améliorer la croissance osseuse, la prévention de troubles de la résorption osseuse et pour la santé des articulations
KR20190001523A (ko) 퍼-부타노일레이티드 n-아세틸-d-만노사민을 포함하는 근디스트로피의 예방 또는 치료용 조성물
NZ725458B2 (en) Muscle atrophy inhibitor containing quercetin glycoside
JP7271016B2 (ja) 骨損失疾患の予防、改善または治療のためのｃｈｐ（シクロ－ヒスプロ）および副甲状腺ホルモンを含む組成物の用途
KR20120055159A (ko) 감국 추출물을 포함하는 불면 증상의 예방 및 개선용 조성물과 그의 제조방법
KR20240101378A (ko) 스티그마스테롤을 유효성분으로 포함하는 근육질환 개선, 예방, 또는 치료용 조성물

Legal Events

Date Code Title Description
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E902 Notification of reason for refusal
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant